SHL Telemedicine Ltd., operating with its subsidiaries, specializes in the development and distribution of individualized telehealth services and medical devices. Their reach extends across Israel, Europe, and various international territories. The company's offerings include a suite of personal 12-lead ECG devices: the Smartheart, a mobile unit designed for the early detection of heart attacks; the CardioSen'C, a personal cellular-digital transmitter; the portable Cardio'B; and the handheld Cardio Beeper 12/12, which is capable of transmitting a complete ECG reading to a centralized monitoring facility.